
Journal of Fluorine Chemistry p. 33 - 39 (2015)
Update date:2022-08-03
Topics: Fluorination Oxidizing agent Experimental conditions N-arylsulfonamides Oxidative fluorination
Buckingham, Faye
Calderwood, Samuel
Checa, Bego?a
Keller, Thomas
Tredwell, Matthew
Collier, Thomas Lee
Newington, Ian M.
Bhalla, Rajiv
Glaser, Matthias
Gouverneur, Véronique
We report a late stage oxidative nucleophilic fluorination of N-arylsulfonamides, a class of compounds so far not considered as precursors to 4-fluorophenyl sulfonamides. By installing a para-positioned tert-butyl substituent on the aniline, oxidative fluorination takes place regioselectively in the presence of HF·pyridine and PIDA. This methodology has been shown to give good yields for a variety of ortho- and meta-functionalised N-arylsulfonamides and has been adapted for radiofluorination to give 4-[18F]fluorophenyl sulfonamides under carrier added conditions.
View MoreQuzhou Hopemax Chemical Technology Co.Ltd
Contact:86-570-3036007
Address:Room 801,Building 2,Wealth Center,No.51,Xujiang Road,Quzhou,China.
PINGYUAN SIHUAN PHARMACEUTICAL CO., LTD
Contact:+86-531-55696072
Address:#2766,yinxiu Road, Economic Development Zone, Pingyuan Country, Shandong Province, China.
Shanxi Tongji Pharmaceuticals Co., Ltd.
Contact:+86-359-3024784
Address:Xikuang South Road, Ruicheng County , Shanxi
Contact:86 21 3772 9386
Address:Rm.1803,Starry Bldg.1,1505 Meijiabang Road,Shanghai 201620 China
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Doi:10.1002/(SICI)1099-1344(199905)42:5<447::AID-JLCR204>3.0.CO;2-9
(1999)Doi:10.1021/ol4026606
(2013)Doi:10.1039/b512177a
(2006)Doi:10.1016/S0960-894X(99)00219-X
(1999)Doi:10.1023/B:RUGC.0000007667.67067.5a
(2003)Doi:10.1248/cpb.55.651
(2007)